Breast Inflammatory Carcinoma — Trials

Breast Inflammatory Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

56 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (12)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01894451	Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy	completed	Early Phase 1	2	Dana-Farber Cancer InstituteOTHER	1	Dec 12, 2019	clinicaltrials
NCT00986609	MUC1 Vaccine for Triple-negative Breast Cancer	completed	Early Phase 1	29	Joseph Baar, MD, PhDOTHER	1	Jul 23, 2018	clinicaltrials